Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00257_DB01218_nanopub.RApAai8ltIFK58z0oEottsqMHzA-HgInXkvsQZCeIoSvY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00257_DB01218 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00257_DB01218 label "DDI between Clotrimazole and Halofantrine - CYP3A4 Inhibitors (Moderate) such as clotrmazole may increase the serum concentration of halofantrine. Extreme caution, with possibly increased monitoring of cardiac status (e.g., ECG), should be used with concurrent use of halofantrine with any moderate CYP3A4 inhibitor(s). [drugbank_resource:DB00257_DB01218]" assertion.
- drugbank_resource:DB00257_DB01218 identifier "drugbank_resource:DB00257_DB01218" assertion.
- drugbank_resource:DB00257_DB01218 title "DDI between Clotrimazole and Halofantrine - CYP3A4 Inhibitors (Moderate) such as clotrmazole may increase the serum concentration of halofantrine. Extreme caution, with possibly increased monitoring of cardiac status (e.g., ECG), should be used with concurrent use of halofantrine with any moderate CYP3A4 inhibitor(s)." assertion.
- drugbank:DB00257 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00257_DB01218 assertion.
- drugbank:DB01218 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00257_DB01218 assertion.